Last ¥748.00 JPY
Change Today +12.00 / 1.63%
Volume 467.0K
4403 On Other Exchanges
Symbol
Exchange
Munich
Tokyo
As of 1:00 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for nof corp (4403)

Year over year, NOF Corporation has been able to grow revenues from ¥148.9B JPY to ¥161.0B JPY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 14.97% to 14.47%. This was a driver that led to a bottom line growth from ¥8.8B JPY to ¥9.7B JPY.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2011
JPY
Mar 31
2012
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
4 Year
Trend
Revenues154,121.0152,364.0148,859.0160,963.0
TOTAL REVENUES154,121.0152,364.0148,859.0160,963.0
Cost of Goods Sold114,756.0113,109.0108,591.0116,743.0
GROSS PROFIT39,365.039,255.040,268.044,220.0
Selling General & Admin Expenses, Total23,282.022,479.022,291.023,295.0
R&D Expenses5,537.05,632.05,655.05,587.0
Depreciation & Amortization, Total81.081.081.084.0
OTHER OPERATING EXPENSES, TOTAL28,900.028,192.028,027.028,966.0
OPERATING INCOME10,465.011,063.012,241.015,254.0
Interest Expense-253.0-247.0-123.0-89.0
Interest and Investment Income624.0704.0760.0880.0
NET INTEREST EXPENSE371.0457.0637.0791.0
Currency Exchange Gains (Loss)-148.0-118.0361.0959.0
Other Non-Operating Income (Expenses)548.0657.0407.0577.0
EBT, EXCLUDING UNUSUAL ITEMS11,236.012,059.013,646.017,581.0
Gain (Loss) on Sale of Investments442.038.0-146.034.0
Gain (Loss) on Sale of Assets---293.09.013.0
Other Unusual Items, Total-1,069.0-869.0-516.0-2,874.0
Legal Settlements---225.0---2,561.0
Other Unusual Items-275.0-442.0-47.0-38.0
EBT, INCLUDING UNUSUAL ITEMS10,609.010,935.012,993.014,754.0
Income Tax Expense3,629.03,546.04,179.05,009.0
Minority Interest in Earnings-94.0-70.0-30.0-8.0
Earnings from Continuing Operations6,980.07,389.08,814.09,745.0
NET INCOME6,886.07,319.08,784.09,737.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS6,886.07,319.08,784.09,737.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS6,886.07,319.08,784.09,737.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4403:JP ¥748.00 JPY +12.00

4403 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,606 INR -4.65
Enzon Pharmaceuticals Inc $1.09 USD +0.01
Nektar Therapeutics $16.67 USD -0.04
Novo Nordisk A/S kr272.90 DKK +3.20
Dow Chemical Co/The $48.67 USD -3.09
View Industry Companies
 

Industry Analysis

4403

Industry Average

Valuation 4403 Industry Range
Price/Earnings 13.0x
Price/Sales 0.8x
Price/Book 1.1x
Price/Cash Flow 13.2x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOF CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.